| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Mohammed Shawkat Razzaque | |
| P2860 | cites work | Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 | Q24290481 |
| Osteocyte control of bone formation via sclerostin, a novel BMP antagonist | Q24300347 | ||
| Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein | Q24309454 | ||
| FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis | Q24319751 | ||
| The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis | Q24625902 | ||
| FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player? | Q24653541 | ||
| Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members | Q24683254 | ||
| Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain | Q28141252 | ||
| FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosis | Q28289695 | ||
| Sclerostin inhibition of Wnt-3a-induced C3H10T1/2 cell differentiation is indirect and mediated by bone morphogenetic proteins | Q28293474 | ||
| FGF23 fails to inhibit uremic parathyroid glands | Q28579798 | ||
| Increased parathyroid expression of klotho in uremic rats | Q28583360 | ||
| Intestinal npt2b plays a major role in phosphate absorption and homeostasis | Q33561684 | ||
| In vivo genetic evidence for suppressing vascular and soft-tissue calcification through the reduction of serum phosphate levels, even in the presence of high serum calcium and 1,25-dihydroxyvitamin d levels | Q33572351 | ||
| Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation | Q33591785 | ||
| Mineral metabolism and aging: the fibroblast growth factor 23 enigma | Q33982618 | ||
| FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. | Q34017992 | ||
| Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging | Q34072221 | ||
| Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule | Q34072230 | ||
| Disease model: human aging | Q34207950 | ||
| Proximal tubular handling of phosphate: A molecular perspective | Q34563763 | ||
| Initial FGF23-mediated signaling occurs in the distal convoluted tubule | Q34695191 | ||
| Klotho: a fundamental regulator of aging | Q34936976 | ||
| STUDIES OF CALCIUM AND PHOSPHORUS METABOLISM : V. A STUDY OF THE BONE TRABECULAE AS A READILY AVAILABLE RESERVE SUPPLY OF CALCIUM | Q35010142 | ||
| Osteocalcin: a pivotal mediator or an innocent bystander in energy metabolism? | Q35025454 | ||
| The dualistic role of vitamin D in vascular calcifications | Q35059753 | ||
| Phosphate toxicity: new insights into an old problem | Q35059905 | ||
| Molecular regulation of phosphate metabolism by fibroblast growth factor-23-klotho system | Q35059924 | ||
| Atomic structure of intracellular amorphous calcium phosphate deposits | Q35080791 | ||
| Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase | Q35126790 | ||
| Inorganic phosphate as a signaling molecule in osteoblast differentiation | Q35541291 | ||
| Crosstransplantation of kidneys in normal and Hyp mice. Evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect | Q35601830 | ||
| A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis | Q35925637 | ||
| Regulation of phosphorus homeostasis by the type iia na/phosphate cotransporter | Q36191092 | ||
| Structural and biochemical properties of fibroblast growth factor 23. | Q36216956 | ||
| Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17 | Q36288869 | ||
| Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism | Q36507256 | ||
| Novel dosage forms and regimens for sevelamer-based phosphate binders | Q36529334 | ||
| FGF23: its role in renal bone disease | Q36577606 | ||
| The kidney and bone metabolism: Nephrologists' point of view. | Q36638034 | ||
| Phosphate transporters: a tale of two solute carrier families. | Q36854464 | ||
| The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis | Q36860289 | ||
| The fallacy of the calcium-phosphorus product | Q36869798 | ||
| High dietary inorganic phosphate increases lung tumorigenesis and alters Akt signaling | Q37041944 | ||
| alpha-Klotho: a regulator that integrates calcium homeostasis | Q37045462 | ||
| In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis | Q37072412 | ||
| Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia | Q37072659 | ||
| Does Fgf23-klotho activity influence vascular and soft tissue calcification through regulating mineral ion metabolism? | Q37182735 | ||
| Disorders of calcium, phosphorus and magnesium metabolism. | Q37340047 | ||
| The roles of Na/Pi-II transporters in phosphate metabolism | Q37397812 | ||
| Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model | Q37415834 | ||
| Calcium and phosphorus homeostasis | Q37418629 | ||
| FGF23 and the parathyroid glands | Q37762995 | ||
| Consequences of phosphate imbalance | Q39548605 | ||
| 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport | Q40397501 | ||
| An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. | Q40482177 | ||
| Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders | Q40530218 | ||
| Cellular/molecular control of renal Na/Pi-cotransport | Q41743339 | ||
| Klotho and Na+,K+-ATPase activity: solving the calcium metabolism dilemma? | Q41900414 | ||
| No bones about it: insulin modulates skeletal remodeling | Q42959815 | ||
| Does FGF23 toxicity influence the outcome of chronic kidney disease? | Q43078080 | ||
| Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients | Q44039636 | ||
| Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study | Q44278022 | ||
| Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia | Q44493980 | ||
| Priliminary trial of low doses of human parathyroid hormone 1-34 peptide in treatment of osteoporosis | Q44867219 | ||
| Severe hyperphosphatemia and hypocalcemia following the rectal administration of a phosphate-containing Fleet pediatric enema | Q44962321 | ||
| High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients | Q44977753 | ||
| Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells | Q45238632 | ||
| Klotho ablation converts the biochemical and skeletal alterations in FGF23 (R176Q) transgenic mice to a Klotho-deficient phenotype | Q46264351 | ||
| Intracellular precipitation of hydroxyapatite mineral and implications for pathologic calcification. | Q46277651 | ||
| Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor 23. | Q46631798 | ||
| Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis | Q46704866 | ||
| Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells | Q46970328 | ||
| Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia | Q48778417 | ||
| Severely reduced production of klotho in human chronic renal failure kidney | Q49064415 | ||
| Renal transplantation in hypophosphatemia with vitamin D-resistant rickets. | Q54421161 | ||
| DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. | Q54943458 | ||
| Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study | Q64111823 | ||
| Fatal poisoning from sodium phosphate enema. Case report and experimental study | Q68967880 | ||
| Intracellular mineralization of Bacterionema matruchotii | Q70789287 | ||
| A fatal small dose of phosphate enema in a young child with no renal or gastrointestinal abnormality | Q73498176 | ||
| Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis | Q73668443 | ||
| Fatal hyperphosphatemia after oral phosphate overdose in a premature infant | Q73851838 | ||
| Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism | Q74288772 | ||
| Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes | Q76378411 | ||
| In vivo mechanisms of hydroxyapatite ceramic degradation by osteoclasts: Fine structural microscopy | Q79288079 | ||
| Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients | Q79478108 | ||
| Trends and dynamics of changes in calcification score over the 1-year observation period in patients on peritoneal dialysis | Q80497742 | ||
| Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism | Q81251002 | ||
| Klotho, FGF23, and FGF receptors in chronic kidney disease: a yin-yang situation? | Q82452774 | ||
| Inflammation, mineral metabolism and progressive coronary artery calcification in patients on haemodialysis | Q82915984 | ||
| The secretory response of parathyroid hormone to acute hypocalcemia in vivo is independent of parathyroid glandular sodium/potassium-ATPase activity | Q83137716 | ||
| Toward a better understanding of Klotho | Q83283214 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 240-247 | |
| P577 | publication date | 2011-03-24 | |
| P1433 | published in | IUBMB Life | Q15764029 |
| P1476 | title | Osteo-renal regulation of systemic phosphate metabolism | |
| P478 | volume | 63 |
| Q37244863 | Can features of phosphate toxicity appear in normophosphatemia? |
| Q37498019 | Can salivary phosphate levels be an early biomarker to monitor the evolvement of obesity? |
| Q35003219 | Dietary and genetic evidence for enhancing glucose metabolism and reducing obesity by inhibiting klotho functions |
| Q24187142 | Dietary interventions for mineral and bone disorder in people with chronic kidney disease |
| Q24201392 | Dietary interventions for mineral and bone disorder in people with chronic kidney disease |
| Q28085476 | Dysregulation of phosphate metabolism and conditions associated with phosphate toxicity |
| Q36504367 | Entpd5 is essential for skeletal mineralization and regulates phosphate homeostasis in zebrafish. |
| Q38087548 | FGF23 associated bone diseases |
| Q43074642 | FGF23-induced hypophosphatemia persists in Hyp mice deficient in the WNT coreceptor Lrp6. |
| Q36992835 | Genetic induction of phosphate toxicity significantly reduces the survival of hypercholesterolemic obese mice |
| Q28535055 | Inadequate awareness among chronic kidney disease patients regarding food and drinks containing artificially added phosphate |
| Q64231913 | Lack of Awareness of Dietary Sources of Phosphorus Is a Clinical Concern |
| Q34119083 | Lack of awareness among future medical professionals about the risk of consuming hidden phosphate-containing processed food and drinks |
| Q42656868 | Targeted Pth4-expressing cell ablation impairs skeletal mineralization in zebrafish |
| Q37485598 | The First Scube3 Mutant Mouse Line with Pleiotropic Phenotypic Alterations. |
| Q37493998 | The rachitic tooth |
| Q36992839 | The role of Klotho in energy metabolism |
| Q36976545 | Toward improved phosphorus efficiency in monogastrics-interplay of serum, minerals, bone, and immune system after divergent dietary phosphorus supply in swine |
| Q38633152 | Vitamin D, phosphate, and vasculotoxicity. |
Search more.